Shanmuga Hospital Ltd
Shanmuga Hospital Ltd, a multispecialty healthcare provider based in Salem, Tamil Nadu, has announced its Initial Public Offering (IPO) to raise ₹20.62 crore. The IPO is scheduled to open on February 13, 2025, and close on February 17, 2025.
Company Overview
Established in 2020, Shanmuga Hospital Ltd operates a 151-bed facility equipped with advanced medical technology. The hospital offers a wide range of services, including:
- Oncology Unit
- High Dependency Unit (HDU)
- Emergency Department (ED)
- Cardiac Care Unit (CCU)
- Intensive Care Unit (ICU)
- Neonatal Intensive Care Unit (NICU)
- Neurosurgery Unit
- Diagnostic Centre with advanced imaging technologies
The hospital is accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH) and the National Accreditation Board for Testing and Calibration Laboratories (NABL), underscoring its commitment to high-quality healthcare services.
IPO Timeline
- Issue Open Date: February 13, 2025
- Issue Close Date: February 17, 2025
- Allotment Finalization: February 18, 2025
- Listing Date: February 21, 2025
Price Band and Lot Size
- Issue Price: ₹54 per equity share
- Face Value: ₹10 per share
- Lot Size: 2,000 shares
- Minimum Investment: ₹108,000
Investors can bid for a minimum of 2,000 equity shares and in multiples thereof.
Financials
The company’s financial performance over the past three fiscal years is as follows:
| Fiscal Year Ended | Revenue (₹ Crores) | Net Profit (₹ Crores) |
|---|---|---|
| March 31, 2022 | 41.47 | 6.72 |
| March 31, 2023 | 39.50 | 4.76 |
| March 31, 2024 | 43.39 | 5.26 |
This data indicates a stable revenue stream with consistent profitability.
Strengths
- Comprehensive Medical Services: Offers a wide range of specialized medical services under one roof.
- Accreditations: Holds NABH and NABL accreditations, reflecting adherence to high-quality standards.
- Strategic Location: Situated in Salem, Tamil Nadu, catering to the healthcare needs of the surrounding regions.
Risks
- Geographical Concentration: Operations are currently limited to a single location, which may limit patient base diversification.
- Regulatory Compliance: The healthcare industry is subject to stringent regulations, and any changes could impact operations.
- Competition: Faces competition from other established hospitals in the region.
IPO Anchor Investors Details
As of now, specific details regarding anchor investors for Shanmuga Hospital Ltd’s IPO have not been disclosed.
IPO Promoter Holding
The promoters of the company are:
- Dr. Panneerselvam Palaniappan Shanmugam
- Dr. Prabu Sankar Panneerselvam
- Dr. Priyadharshni Dhandapani
- Mrs. Jayalakshmi Panneerselvam
Their collective shareholding details prior to and post-IPO have not been specified.
IPO Grey Market Premium (GMP)
As of February 12, 2025, there is no available information regarding the Grey Market Premium for Shanmuga Hospital Ltd’s IPO.
Final Thoughts
Shanmuga Hospital Ltd’s IPO offers investors an opportunity to invest in a healthcare provider with a comprehensive range of services and recognized accreditations. The hospital’s established presence in Salem and its commitment to quality healthcare are notable strengths. However, potential investors should consider the risks associated with geographical concentration and regulatory compliance. Conducting thorough due diligence is recommended before making investment decisions.